Benzaclin and Zofran drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Benzaclin (benzoyl peroxide; clindamycin phosphate) and Zofran (ondansetron hydrochloride). Common drug interactions include chronic kidney disease among females and dermatitis among males.

The phase IV clinical study analyzes what interactions people have when they take Benzaclin and Zofran. It is created by eHealthMe based on reports of 16 people who take the same drugs from the FDA, and is updated regularly.

What is Benzaclin?

Benzaclin has active ingredients of benzoyl peroxide; clindamycin phosphate. It is often used in acne. eHealthMe is studying from 477 Benzaclin users. Check the latest studies of Benzaclin.

What is Zofran?

Zofran has active ingredients of ondansetron hydrochloride. It is often used in nausea. eHealthMe is studying from 94,987 Zofran users. Check the latest studies of Zofran.



On Jul, 19, 2026

16 people who take Benzaclin and Zofran together, and have interactions are studied.

Benzaclin and Zofran drug interactions.

What are the common drug interactions of Benzaclin and Zofran, by gender? *:

female:

  1. Chronic kidney disease
  2. Injury
  3. Pain
  4. Renal failure (kidney dysfunction)
  5. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  6. Anxiety
  7. Biliary dyskinesia (motility disorder that affects the gallbladder and sphincter of oddi)
  8. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  9. Crohn's disease (a condition that causes inflammation of the gastrointestinal tract)
  10. Decreased appetite

male:

  1. Dermatitis (inflammation of the skin resulting from direct irritation by an external agent or an allergic reaction to it)
  2. Mucosal inflammation (infection of mucous membrane)
  3. Malignant neoplasm progression (cancer tumour came back)
  4. Obstructive airways disorder (a progressive disease that makes it hard to breathe)
  5. Poor quality sleep
  6. Somnolence (a state of near-sleep, a strong desire for sleep)
  7. Tonsillar hypertrophy (enlargement of the tonsils)
  8. Urticaria (rash of round, red welts on the skin that itch intensely)
  9. Cellulitis (infection under the skin)
  10. Sinusitis (inflammation of sinus)

What are the common drug interactions of Benzaclin and Zofran, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Circadian rhythm sleep disorder (family of sleep disorders affecting, among other things, the timing of sleep)
  2. Crohn's disease (a condition that causes inflammation of the gastrointestinal tract)
  3. Dyspepsia (indigestion)
  4. Haematocrit decreased
  5. Haemoglobin decreased
  6. Injury
  7. Insomnia (sleeplessness)
  8. Obstructive airways disorder (a progressive disease that makes it hard to breathe)
  9. Pain
  10. Poor quality sleep

20-29:

  1. Urticaria (rash of round, red welts on the skin that itch intensely)

30-39:

n/a

40-49:

  1. Chronic kidney disease
  2. Nephrogenic anaemia (anaemia due to kidney disease)
  3. Renal failure (kidney dysfunction)

50-59:

  1. Dermatitis (inflammation of the skin resulting from direct irritation by an external agent or an allergic reaction to it)
  2. Mucosal inflammation (infection of mucous membrane)
  3. Malignant neoplasm progression (cancer tumour came back)

60+:

  1. Cellulitis (infection under the skin)
  2. Sinusitis (inflammation of sinus)
  3. Injury
  4. Pain
  5. Sputum increased
  6. Sputum purulent
  7. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  8. Anxiety
  9. Biliary dyskinesia (motility disorder that affects the gallbladder and sphincter of oddi)
  10. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)

What are the existing conditions these people have? *

  1. Pain: 6 people, 37.50%
  2. Constipation: 4 people, 25.00%
  3. Diabetes: 3 people, 18.75%
  4. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 18.75%
  5. Oral Pain: 3 people, 18.75%
  6. Oral Cancer (mouth cancer): 3 people, 18.75%
  7. Immunodeficiency Common Variable: 3 people, 18.75%
  8. High Blood Pressure: 2 people, 12.50%
  9. Hypersensitivity: 2 people, 12.50%
  10. Dermatitis Atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder): 1 person, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Benzaclin and Zofran?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Benzaclin and Zofran:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Benzaclin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Zofran:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Benzaclin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Zofran and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on benzoyl peroxide; clindamycin phosphate and ondansetron hydrochloride (the active ingredients of Benzaclin and Zofran, respectively), and Benzaclin and Zofran (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: